TREA

79299574 - NEURODERM

Follow

Information

  • Trademark
  • 79299574
  • Serial Number
    79299574
  • Registration Number
    6358631
  • Filing Date
    May 04, 2020
    4 years ago
  • Registration Date
    May 25, 2021
    3 years ago
  • Transaction Date
    July 30, 2022
    2 years ago
  • Status Date
    May 25, 2021
    3 years ago
  • Published for Opposition Date
    March 09, 2021
    4 years ago
  • Location Date
    June 09, 2021
    3 years ago
  • Status Code
    700
  • Current Location
    TMO LAW OFFICE 111
    Employee Name
    ADORNO SANTOS, LUZ M.
  • Attorney Docket Number
    T-14315-US-I
    Attorney Name
    A. Tally Eitan
    Law Office Assigned Location Code
    M20
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
NEURODERM
Case File Statements
  • B00001: In the statement, " International Class 5 " is corrected per the restriction and the fnote dated 5/25/2021
  • GS0051: Pharmaceuticals, namely, pharmaceutical preparations for use in preventing and treating conditions, diseases, or disorders of the central nervous, neurological, cardiovascular, endocrine, gastric or gastroenteric, hematologic, immunologic, inflammatory, osteologic, or respiratory systems; pharmaceutical preparations for use in prevention and treatment of allergies or allergic responses, metabolic disorders, psychiatric and emotional disorders, infection and infectious diseases, pain; drug delivery kits comprising dressings for medical, surgical, and veterinary use [ ; drug delivery agents, namely, transdermal patches sold with medication for use in the treatment of conditions, diseases or disorders of the central nervous, neurological, cardiovascular, endocrine, gastric or gastroenteric, hematologic, immunologic, inflammatory, osteologic, or respiratory systems ]
  • GS0101: Medical devices for delivery of medicated and pharmaceutical preparations, namely, implantable drug delivery pumps, drug delivery catheters, drug delivery patches sold without medication, subcutaneous drug delivery pumps, subcutaneous drug delivery patch pumps, refillable drug delivery pumps, and infusion drug delivery pumps; drug delivery device sold empty, namely, syringes, infusion drug delivery pumps; infusion sets; electromagnetic drug delivery apparatus for medical use; medical apparatus, namely, implantable ports; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus and medical instruments for administering fluid, drugs, and nutrition, namely, infusion pumps, patch pumps being adherable subcutaneous drug delivery pumps, wearable medication injectors, wearable subcutaneous drug delivery pumps, and handheld medication injectors; medical syringes; medical devices in the nature of infusion pumps for drug infusion and for monitoring the infusion of drugs with integrated recorded software for transmission and receiving of drug infusion data, data related to the infusion pumps, drug infusion monitoring, filling and emptying of drug vials, and patient's behavior and reaction to drugs, sold as a unit therewith; drug delivery devices, namely, catheters, injection pen needles, injection needles, injection syringes and implantable subcutaneous drug delivery pumps; lancets; medical lancing devices for delivering medication, sold empty; drug eluting stents; bio-absorbable stents; synthetic stent grafts; medical diagnostic apparatus used to detect and measure the level of substances in body fluids; medical apparatus for measuring dosages and delivering pharmaceuticals, namely, infusion drug delivery pumps, subcutaneous drug delivery wearable pumps, subcutaneous drug delivery patch pumps, implantable drug delivery pumps and injection pens; electromedical rehabilitative and pain management products for clinical and home use, namely, electrical nerve and muscle stimulators, ultrasonic stimulators, magnet therapy stimulators and laser therapy stimulators; electronickinetic transdermal drug delivery control unit for the treatment of diseases
Case File Event Statements
  • 7/30/2022 - 2 years ago
    39 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 6/9/2022 - 2 years ago
    38 - INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE Type: INNA
  • 2/9/2022 - 3 years ago
    37 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR
  • 10/4/2021 - 3 years ago
    36 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 9/11/2021 - 3 years ago
    35 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 9/11/2021 - 3 years ago
    34 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 8/25/2021 - 3 years ago
    33 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 6/10/2021 - 3 years ago
    32 - LIMITATION FROM THE IB EXAMINED AND ENTERED Type: LIME
  • 6/9/2021 - 3 years ago
    31 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 6/9/2021 - 3 years ago
    30 - CORRECTION UNDER SECTION 7 ¿ PROCESSED Type: COC.
  • 6/9/2021 - 3 years ago
    29 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 5/25/2021 - 3 years ago
    28 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/23/2021 - 3 years ago
    27 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG
  • 3/22/2021 - 3 years ago
    26 - LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: LIMN
  • 3/15/2021 - 3 years ago
    25 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 3/9/2021 - 4 years ago
    24 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/9/2021 - 4 years ago
    23 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/28/2021 - 4 years ago
    22 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG
  • 2/24/2021 - 4 years ago
    21 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 2/24/2021 - 4 years ago
    20 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 2/17/2021 - 4 years ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/2/2021 - 4 years ago
    18 - ASSIGNED TO LIE Type: ALIE
  • 2/2/2021 - 4 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/2/2021 - 4 years ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/2/2021 - 4 years ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 2/2/2021 - 4 years ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 2/2/2021 - 4 years ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 2/1/2021 - 4 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/1/2021 - 4 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/1/2021 - 4 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/24/2021 - 4 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 12/30/2020 - 4 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 12/29/2020 - 4 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 12/15/2020 - 4 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 12/15/2020 - 4 years ago
    5 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 12/14/2020 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/11/2020 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/11/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 12/10/2020 - 4 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR